特立妥单抗
Anti-Human CD3xBCMA Bispecific Antibody(Teclistamab )
ChemLeader
Catalog No:
CAS No.:
MDLNo:
Formula:
MW:
Size
Quantity
- +
Product Overview
Product Name Anti-Human CD3xBCMA Bispecific Antibody(Teclistamab )
CAS2119595-80-9
Storage condition -80°C for one-year storage. Avoid repeated freeze-thaw.
Security information
Product details

Teclistamab is a human bispecific antibody to BCMA and CD3 that recognizes BCMA on target cells and CD3 on T cells and induces T cell-mediated cytotoxicity leading to T cell activation and subsequent target cell lysis. Teclistamab can be used in studies of diseases related to multiple myeloma (MM).

Related literature
Related
Sorry, no related items
History
Alacizumab (Anti-VEGFR2 / KDR / CD309)
Dalotuzumab (Anti-IGF1R / CD221)
Tovetumab (Anti-PDGFRA / CD140a)
Brontictuzumab (Anti-NOTCH1)
Anti-Human CD3xBCMA Bispecific Antibody(Teclistamab )
Tixagevimab (Synonyms: AZD8895)
Anti-Human CTLA4xLAG3 Bispecific Antibody ( Bavunalimab; XmAb-22841;cytotoxic T-lymphocyte-associated protein 4, CD152;lymphocyte activating 3, lymphocyte-activation 3, CD223)
Sinigrin (Synonyms: Allyl-glucosinolate; 2-Propenyl-glucosinolate)
Abrilumab (Anti-Integrin a4b7 ITGA4 & ITGB7)
Anti-Human CD3xCD20 (Synonyms: Glofitamab; RO7082859; CD20-TCB ,RG-6026;CD3e, CD3 epsilon;membrane-spanning 4-domains subfamily A member 1, CD20,MS4A1)